Archives
Candida krusei Forms Trigger Distinct BMEC Apoptosis
2026-10-03
Miao et al. show that the yeast and hypha phases of Candida krusei both induce apoptosis in bovine mammary epithelial cells, but with different dominant signaling features. The yeast phase was associated mainly with mitochondrial dysfunction, whereas the hypha phase was linked more strongly to death ligand/receptor signaling, with TLR2/ERK and JNK/ERK pathways involved in both responses.
Staurosporine in Matrix-Aware Cancer Research
2026-10-02
Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor that can reveal how extracellular matrix context reshapes cancer-cell signaling and apoptosis. This article translates type III collagen findings into a matrix-aware framework for cancer research, angiogenesis studies, and reproducible assay interpretation.
Linoleic Acid C3108: Practical Assay Workflow
2026-10-01
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a defined lipid input for membrane, redox, erythrocyte, migration, and essential fatty acid experiments. It is suited to controlled in vitro and nutritional deficiency workflows, but should not be treated as evidence of a universal pathway effect or stored as a long-term solution.
Recombinant Human Oncostatin M: Fibrosis Assays
2026-10-01
Use rh-Oncostatin M as a defined inflammatory and fibroproliferative stimulus in cell-based assays, from fibroblast proliferation to endothelial cytokine release. This workflow connects OSM biology with mast cell–mesothelial fibrosis research while separating established product performance from testable experimental hypotheses.
DNMT3B, NEPC, and the Translational Case for Nanaomycin A
2026-09-30
A translational perspective on how DNMT3B links androgen-deprivation pressure to neuroendocrine prostate cancer, and how (S,S)-Nanaomycin A can help researchers test lineage plasticity, stemness, and tumor-maintenance biology.
Indole-3-pyruvic Acid: Applied Research Workflows
2026-09-30
Indole-3-pyruvic acid connects auxin-pathway analysis, fungal metabolite tracing, and AhR-focused immune studies in one versatile workflow. This guide translates pathway biology into practical assay design, controls, handling conditions, and troubleshooting strategies.
ARL4C Links Synoviocyte Growth to RA Progression
2026-09-29
The reference study integrates single-cell and bulk transcriptomics with cellular perturbation, macrophage co-culture, and collagen-induced arthritis experiments to identify ARL4C as a regulator of rheumatoid arthritis progression. Its findings connect ARL4C-dependent fibroblast-like synoviocyte proliferation and invasiveness with macrophage polarization, while suggesting that direct S-phase measurements could strengthen future mechanistic and pharmacodynamic studies.
PI3K Pathway Combinations in Ocular Angiogenesis
2026-09-29
Sasore and Kennedy evaluated combinations of PI3K/AKT/mTOR pathway inhibitors in complementary zebrafish models of vascular growth and ocular development. Their central contribution was to show that anti-angiogenic potency and ocular tolerability are combination-specific, with NVP-BEZ235 plus PI-103 producing a particularly favorable phenotype in developing larvae.
L-Glutathione Reduced for Redox Research
2026-09-28
L-Glutathione Reduced provides a practical thiol-based control for oxidative-stress experiments, GST affinity workflows, and cancer-metabolism studies. This guide connects fresh-solution handling and assay design with the GOT1–glutamine metabolism findings reported in pancreatic cancer research.
CLCC1 Drives Herpesvirus Nuclear Egress Fusion
2026-09-28
A whole-genome CRISPR screen identified CLCC1 as a host factor required for efficient herpes simplex virus 1 nuclear egress, addressing the poorly understood membrane-fusion step after viral capsids bud into the perinuclear space. The findings connect this viral exit route with nuclear pore insertion and point to a cellular membrane-remodelling function, while leaving open whether CLCC1 acts directly as a fusion component.
miR-18a–ALOXE3 Signaling Drives GBM Progression
2026-09-27
The study links elevated miR-18a and reduced ALOXE3 to two features of glioblastoma progression: resistance to ferroptotic cell death and increased tumor-cell migration. By combining human tumor analysis, cellular perturbation, lipid-mediator studies, and orthotopic mouse modeling, it identifies a miR-18a–ALOXE3 axis that may help explain how altered lipid metabolism contributes to GBM development.
Redox Context in GOT1-Driven PDAC Research
2026-09-26
GOT1 inhibition can disrupt pancreatic cancer metabolism and redox balance, but that does not establish glutathione as the mechanism. Learn how to use L-Glutathione Reduced as a disciplined experimental probe in translational research.
Caffeine: Mechanism, Evidence, and Research Use
2026-09-25
Caffeine (1,3,7-trimethylpurine-2,6-dione) is an adenosine receptor antagonist used to study neuronal activity and energy metabolism modulation. Product-level evidence reports cancer cell line inhibition in selected sarcoma models and metabolic effects in a diet-induced obesity mouse model; neither finding establishes a clinical treatment effect.
Apicidin Beyond HDAC Potency: Interpreting Cell Effects
2026-09-25
Apicidin is a potent histone deacetylase inhibitor, but its effects depend on cell type, exposure, and the endpoint measured. This article connects HDAC target engagement with cancer and oocyte assay interpretation, highlighting what the evidence supports—and what it does not.
PSI-7977 and Disulfidptosis: Evidence Boundaries
2026-09-24
PSI-7977 is linked here with a careful guide to what current evidence does—and does not—show about BAP1, SLC7A11, and disulfidptosis. Learn how to translate the 2024 findings into more interpretable cell-death experiments without assigning an unsupported role to the product.